Pfizer Inc

By root | December 18, 2005 AAA

Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Investing Basics

    What are examples of major companies in the drugs sector?

  2. Mutual Funds & ETFs

    Top Short Leveraged Oil ETFs, ETNs

  3. Stock Analysis

    How is a Spinoff Worth $100 Billion? See AbbVie

  4. Chart Advisor

    Consider Buying These Uptrending Stocks

  5. Bonds & Fixed Income

    A Look at the Pros and Cons of Muni Bonds

Trading Center